MedPath

Study to assess effect of Ayurvedic drugs on Recurrent Allergic conjunctivitis

Phase 2
Conditions
Health Condition 1: H102- Other acute conjunctivitis
Registration Number
CTRI/2023/07/055497
Lead Sponsor
ational Institute of Ayurveda Deemed to be University Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Patients presenting with signs and symptoms of Kaphaja Abhishyanda described as per Ayurvedic texts and Vernal Keratoconjunctivitis diagnosed by â??Japanese Guideline for allergic conjunctival disease.

• Age from 5-25 years

Exclusion Criteria

Patients affected by other allergic ocular disease such as Atopic KeratoConjuctivitis,Giant Papillary Conjunctivitis and Seasonal Allergic Conjunctivitis.

• Patients under eye drop or systemic treatments for other disease.

• Cases complicated with corneal pannus ,corneal neovascularization ,corneal ulcer, keratoconus and corneal plaques .

• Contact lens wearers.

•Patients suffering from other systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess and compare the efficacy of topical and systemic Ayurvedic drugs in the patients with VKCTimepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
To assess the safety & ocular tolerance of shigru madhu saindhava ashchyotana in patients with VKCTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath